Prevention of infection refers to the ability of the vaccine to protect individuals from becoming infected with the tuberculosis (TB) bacteria. A person cannot get TB disease if this person does not get infected. A person who is already infected with the TB bacteria prior to vaccination, may still develop TB disease in this case.
Advancing evidence-informed in-country decision-making for new TB vaccine introduction: A responsive and integrated vaccine modelling approach from India
As new TB vaccines move into late-stage development, it is imperative for high-burden
countries like India to ensure timely and effective evidence-generation to inform decision-making
and accelerate vaccine development and introduction. To enable this, an in-country vaccine
mathematical modelling effort has been initiated in India.